Export of Celltrion’s COVID-19 antibody treatment ‘Regkirona (regdanvimab)’ is now fully on track.

On the 9th, Celltrion Healthcare announced that it had completed shipping 150,000 vials of the initial load of Regkirona for 9 countries in Europe.

Celltrion Healthcare has been discussing exporting Regkirona with 70 countries. In addition to the 9 countries that the company is supplying its initial load to, the company has signed supply agreements with a total of 18 countries. The total amount that has been and will be supplied in December alone is expected to reach ₩150 billion.

Demand for the supply of Regkirona has been increasing due to the increased product rel